NR3C1 and depressive symptom measurement: EMO ameliorates chronic unpredictable mild stress (CUMS) induced depression-related behaviors by altering the glucocorticoid receptor (GR) and brain-derived neurotrophic factor (BDNF) levels in the hippocampus [16].